D&A at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Globus Medical's d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Globus Medical's D&A?
- Globus Medical (GMED) reported D&A of $69.86M in Q1 2026.
- How has Globus Medical's D&A changed year-over-year?
- Globus Medical's D&A increased by 6.4% year-over-year, from $65.65M to $69.86M.
- What is the long-term trend for Globus Medical's D&A?
- Over 4 years (2021 to 2025), Globus Medical's D&A has grown at a 41.1% compound annual growth rate (CAGR), from $69.87M to $276.84M.
- What does D&A mean?
- The non-cash cost of wearing out equipment and using up intangible assets.
- How do you interpret D&A?
- High levels relative to revenue may indicate a capital-intensive business model with significant asset bases.
- How does D&A compare across companies?
- Standard for manufacturing and medical device companies with significant property, plant, and equipment.